Last edition
News about "Peter Bains"
Syngene Renews Long-Term Research Alliance with Bristol Myers Squibb Until 2035
Syngene International has extended its long-term research collaboration with Bristol Myers Squibb until 2035, expanding the partnership to cover integrated services across the drug development lifecycle, from discovery and translational sciences to manufacturing, clinical trials and commercialisation support.
Peter Bains | 20/01/2026 | By News Bureau
Syngene International Invests in Peptide Laboratory and Advanced Automation
Syngene International has set up a dedicated peptide laboratory equipped with advanced automation technologies to accelerate hit-to-lead timelines. The investment enhances the company’s integrated drug discovery and development capabilities, reinforcing its position as a leading partner for end-to-end research solutions.
Peter Bains | 16/10/2025 | By Dineshwori | 270
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy